Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1968
Report date:
1968

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Standardised study to determine the acute toxicity of the test item in mice after single i.p. application.
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
2-piperazin-1-ylethanol
EC Number:
203-142-3
EC Name:
2-piperazin-1-ylethanol
Cas Number:
103-76-4
Molecular formula:
C6H14N2O
IUPAC Name:
2-piperazin-1-ylethanol
Test material form:
liquid

Test animals

Species:
mouse
Strain:
other: Kisslegg
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 15-34 g

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
water
Doses:
200, 400, 640, 800 cm³/kg bw (212, 424, 678, 848 mg/kg bw - conversation in mg/kg is based on the density: d= 1.06 g/cm³)
The doses were administered as aqueous solutions of 8% (800, 640 cm³/kg), 4% (400 cm³/kg) and 2% (200 cm³/kg) test substance.
No. of animals per sex per dose:
5
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 7 days
- Frequency of observations: daily
- Frequency of weighing: before the start of the study
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
< 678 mg/kg bw
Based on:
test mat.
Remarks on result:
other: Corresponds to 640 cm³/kg bw; the mg/kg was calculated on the density d: d= 1.061 g/cm³. 678 mg/kg bw : all female and 2 male animals died within 48 hours post application; 424 mg/kg bw: one male and one female animal died within 7 days post application.
Mortality:
848 mg/kg bw : all animals died within 48 hours post application
678 mg/kg bw : all female and 2 male animals died within 48 hours post application
424 mg/kg bw: one male and one female animal died within 7 days post application
Clinical signs:
Immediately after application, labored respiration, aqueous secretion from the oral cavity, shrunken flanks, high stepping gait, indicated morphine tails, abdominal position and closed eyes were observed. During the following days, the surviving animals showed clotted eyes, scrubby fur, accelerated respiration. 5 to 6 days after exposure, no clinical signs were observed.
Body weight:
no data
Gross pathology:
Animals that died: clear odor of test substance, livers with bloody pigmentation, intestine filled with bloody fluids
Animals examined at termination of the study: connation of liver and stomach

Applicant's summary and conclusion